Ki-67 and Bax expression in esophageal mucosa might have implications in ablative therapies for Barrett’s esophagus, dysplasia, and adenocarcinoma

Jannis Kountouras; Dimitrios Chatzopoulos; Christos Zavos; Georgia Deretzi; Stergios A. Polyzos; Emmanuel Gavalas; Philippos Klonizakis; Elizabeth Vardaka; Panagiotis Katsinelos; Christos Stergiopoulos

首页> 外文期刊>Surgical Endoscopy >Ki-67 and Bax expression in esophageal mucosa might have implications in ablative therapies for Barrett’s esophagus, dysplasia, and adenocarcinoma

【24h】

Ki-67 and Bax expression in esophageal mucosa might have implications in ablative therapies for Barrett’s esophagus, dysplasia, and adenocarcinoma

机译：食管粘膜中Ki-67和Bax的表达可能对巴雷特食管，不典型增生和腺癌的消融治疗有影响

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Surgical Endoscopy》 |2012年第1期|p.283-284|共2页
作者
Jannis Kountouras; Dimitrios Chatzopoulos; Christos Zavos; Georgia Deretzi; Stergios A. Polyzos; Emmanuel Gavalas; Philippos Klonizakis; Elizabeth Vardaka; Panagiotis Katsinelos; Christos Stergiopoulos;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Ki-67 and Bax expression in esophageal mucosa might have implications in ablative therapies for Barrett's esophagus, dysplasia, and adenocarcinoma. [J] . Kountouras J, Chatzopoulos D, Zavos C, Surgical Endoscopy . 2012,第1期

机译：食管粘膜中Ki-67和Bax的表达可能对巴雷特食管，不典型增生和腺癌的消融治疗有影响。
2. Reply to Letter to the Editor: Re: Comparison of COX-2, Ki-67, and BCL-2 expression in normal esophageal mucosa, Barrett’s esophagus, dysplasia, and adenocarcinoma with postablation mucosa and implications for ablative therapies (Online First) [J] . Sri Ganeshamurthy Thrumurthy, Christopher John Lewis, Susan Pritchard, Surgical Endoscopy . 2012,第1期

机译：回复编辑的信：关于：正常食管粘膜，巴雷特食管，异型增生和腺癌伴消融后粘膜的COX-2，Ki-67和BCL-2表达的比较及其对消融疗法的影响（在线优先）
3. Reply to letter to the editor: Re: Comparison of COX-2, Ki-67, and BCL-2 expression in normal esophageal mucosa, Barrett's esophagus, dysplasia, and adenocarcinoma with postablation mucosa and implications for ablative therapies (Online First). [J] . Thrumurthy SG, Lewis CJ, Pritchard S, Surgical Endoscopy . 2012,第1期

机译：回复编辑的信：关于：正常食管粘膜，巴雷特食管，异型增生和腺癌伴消融后粘膜的COX-2，Ki-67和BCL-2表达的比较及其对消融疗法的影响（在线优先）。
4. Barrett's esophagus: photodynamic therapy for ablation of dysplasia reduction of specialized mucosa and treatment of superficial esophageal cancer [C] . Bergein F. Overholt, M.D., Thompson Cancer Survival Ctr., 5th International Photodynamic Association Biennial Meeting . 1995

机译：巴雷特食管：光动力疗法用于减少特殊粘膜异常增生的消融术和浅表食道癌的治疗
5. Signal Transduction in Barrett's Esophagus and Esophageal Adenocarcinoma [D] . Narendran, Nirushan Harushikesh. 2018

机译：巴雷特食管和食道腺癌中的信号转导
6. Mucosa-Associated Microbiota in Barretts Esophagus Dysplasia and Esophageal Adenocarcinoma Differ Similarly Compared With Healthy Controls [O] . Shajan Peter, Amanda Pendergraft, William VanDerPol, 2020

机译：与健康对照相比Barrett食管和食管腺癌和食管腺癌的粘膜相关的微生物群不同
7. Immunohistochemical Expression of Ki-67, PCNA, pRb, p16, p53, Bcl-2 and Bax in Esophageal Adenocarcinoma and Barrett’s Associated Dysplasia [O] . Andrey Iskrenov Kotzev, Margarita Angelova Kamenova, Alexander Petrov Tcherveniakov 2012

机译：Ki-67，PCNA，pRb，p16，p53，Bcl-2和Bax在食管腺癌和Barrett相关性异型增生中的免疫组织化学表达

Ki-67 and Bax expression in esophageal mucosa might have implications in ablative therapies for Barrett’s esophagus, dysplasia, and adenocarcinoma

著录项

相似文献

相关主题

期刊订阅